InvestorsHub Logo
Followers 31
Posts 4225
Boards Moderated 0
Alias Born 07/25/2007

Re: DewDiligence post# 2331

Thursday, 11/10/2022 2:30:57 AM

Thursday, November 10, 2022 2:30:57 AM

Post# of 3133

ENTA starts phase-2 trial of EDP-235 in non-hospitalized, standard-risk COVID patients:......Data are expected in 1H23. I had been hoping for a pivotal phase-2/3 trial. but either ENTA or the FDA evidently didn’t like that idea.




I was hoping the same. Maybe ENTA decided they didn't have the experience to run a phase 3 or they didn't want to risk the money. If the phase 2 data is good they will seek a partnership. Hell, they may have an interested suitor waiting in the wings to see what happens.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent ENTA News